| Feb 19 2016 |
Cutting Corners in Cheese |
Keller and Heckman LLP |
| Feb 18 2016 |
California Provision Goes Slack re: Food Law |
Keller and Heckman LLP |
| Feb 18 2016 |
Sandoz Asks Supreme Court To Reverse Biosimilar Decision |
Foley & Lardner LLP |
| Feb 17 2016 |
FDA Aims to Expand Sentinel Capabilities, Include Evaluation of Drug Effectiveness |
McDermott Will & Emery |
| Feb 17 2016 |
60-Day Rule Is Final: Assessing Your Organization’s Safeguards |
Morgan, Lewis & Bockius LLP |
| Feb 17 2016 |
CMS Relaxes 60-day Overpayment “Look Back” Period for Medicare Providers |
Barnes & Thornburg LLP |
| Feb 17 2016 |
FCA Claims Based on Average Wholesale Price Theory Barred by Public Disclosure Bar |
McDermott Will & Emery |
| Feb 17 2016 |
Cannabis-Related Contract Enforcement: Solution Presents Itself? |
Wilson Elser Moskowitz Edelman & Dicker LLP |
| Feb 17 2016 |
Menu Labeling in the House: FDA Requirements |
Keller and Heckman LLP |
| Feb 16 2016 |
CMS Notifies States of AMP Rule Requirements: 340B Providers Should Take Note |
Mintz |
| Feb 16 2016 |
Gluten-Free Go-Round re: Food Labeling |
Keller and Heckman LLP |
| Feb 13 2016 |
USDA Announces New Standards to Reduce Salmonella and Campylobacter in Poultry |
Morgan, Lewis & Bockius LLP |
| Feb 13 2016 |
CMA Fines GlaxoSmithKline and Several Generic Companies £45 million for Delaying Market Entry of Generic Paroxetine in the UK |
Covington & Burling LLP |
| Feb 12 2016 |
FDA Issues Draft Guidance for Connected Medical Devices |
Jackson Lewis P.C. |
| Feb 12 2016 |
TTB Issues Ruling on Category Management under Federal Tied-House Statute |
McDermott Will & Emery |
| Feb 12 2016 |
Cannabidiol: (Clinical) Trials and Tribulations |
Keller and Heckman LLP |
| Feb 12 2016 |
What the Administration Actually Can Do on Drug Pricing |
Mintz |
| Feb 11 2016 |
FDA Panel Shows Strong Support for Remicade Biosimilar |
Foley & Lardner LLP |
| Feb 11 2016 |
Recent Revisions to Internal Revenue Code Affecting Alcohol Beverages |
McDermott Will & Emery |
| Feb 11 2016 |
Soda Shakedown re: Sugar Tax |
Keller and Heckman LLP |
| Feb 11 2016 |
Remicade Biosimilar Closer To Approval, But Patent Dance Goes On |
Foley & Lardner LLP |
| Feb 10 2016 |
Positive FDA Advisory Committee Vote for First Monoclonal Antibody Biosimilar – But Will Patent Dispute Delay Launch? |
Mintz |
| Feb 10 2016 |
Drug Shortages are Forcing Treatments to be Rationed |
Stark & Stark |
| Feb 10 2016 |
FDA Unveils Action Plan to Combat Opioid Abuse |
Foley & Lardner LLP |
| Feb 10 2016 |
First Monoclonal Antibody Biosimilar in U.S. Gets One Step Closer to FDA Approval |
Mintz |
| Feb 10 2016 |
PTAB Institutes Trial On Previously Challenged Cabilly Patent |
Foley & Lardner LLP |
| Feb 10 2016 |
Deciphering Final AMP Rule – Key Provisions Impacting Pharmacies, PBMs, and Manufacturers |
Mintz |
| Feb 10 2016 |
FDA Food Funding for FY 2017 |
Keller and Heckman LLP |
| Feb 10 2016 |
USDA Declares “Do-Over” on Overhaul of Biotechnology Regulations |
Beveridge & Diamond PC |
| Feb 9 2016 |
FDA Issues Draft Guidance on ‘Emerging Signals’ |
Morgan, Lewis & Bockius LLP |
| Feb 9 2016 |
Cheese Controls re: FDA Safety Criteria |
Keller and Heckman LLP |
| Feb 8 2016 |
California Court Curbs Chipotle GMO Case |
Keller and Heckman LLP |
| Feb 5 2016 |
China Food Law: Year in Review 2015 Part II |
Keller and Heckman LLP |
| Feb 5 2016 |
Sounds Fishy: New Seafood Traceability Program |
Keller and Heckman LLP |
| Feb 5 2016 |
Coalition for Affordable Drugs V LLC v. Biogen International GmbH - Denying Rehearing of Decision Not to Institute Based on Lack of Showing of Abuse of Discretion IPR2015-01086 |
Faegre Drinker |
